Goldman Sachs Group »

Aurinia Pharmaceuticals shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Aurinia Pharmaceuticals (AUPH) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Aurinia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Aurinia Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aurinia Pharmaceuticals by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $13M 2.3M 5.71
2024-03-31 $11M 2.2M 5.01
2023-12-31 $18M 2.0M 8.99
2023-09-30 $11M 1.5M 7.77
2023-06-30 $17M 1.7M 9.68
2023-03-31 $11M 990k 10.96
2022-12-31 $2.0M 471k 4.32
2022-06-30 $7.2M 720k 10.05
2022-03-31 $3.8M 310k 12.38
2021-12-31 $6.3M 273k 22.87
2021-09-30 $3.9M 176k 22.13
2021-03-31 $3.9M 300k 12.98
2020-12-31 $2.4M 172k 13.83
2020-09-30 $2.6M 180k 14.73
2020-06-30 $4.4M 269k 16.25
2019-12-31 $13M 623k 20.26
2019-09-30 $8.8M 1.7M 5.34
2019-06-30 $7.5M 1.1M 6.58
2019-03-31 $9.0M 1.4M 6.50
2018-12-31 $11M 1.7M 6.83
2018-09-30 $12M 1.7M 6.64
2018-06-30 $10M 1.8M 5.63
2018-03-31 $6.4M 1.2M 5.19
2017-12-31 $5.4M 1.2M 4.53
2017-09-30 $5.5M 875k 6.27
2017-06-30 $5.4M 877k 6.13
2017-03-31 $3.7M 502k 7.34
2016-12-31 $2.7M 1.3M 2.10
2016-09-30 $1.1M 375k 3.01
2016-03-31 $61k 21k 2.89